Literature DB >> 8453506

Increased bone growth by local prostaglandin E2 in rats.

R S Yang1, T K Liu, S Y Lin-Shiau.   

Abstract

The effects of prostaglandin E2 (PGE2) on bone growth were investigated in rats. Daily injection of PGE2 (1, 10, and 100 pmol) was given via local intraosseous route into the metaphysis of the left tibia for 14 days. The contralateral right tibia injected with vehicle and saline was for the control. The rats receiving no injection provided as normal control. The results obtained indicated that PGE2 slightly but significantly decreased the body weight increment without effect on tibial length. The most prominent effect of PGE2 was the increase of metaphyseal bone trabeculae by 45-81% in a dose-dependent manner. The microscopic examination revealed that PGE2 unequivocally increased the new woven bone formation. The bone cell population study showed no difference between the number of osteoblasts and osteoclasts in primary spongiosa of the PGE2-injected limbs and those of contralateral limbs. However, the numbers of osteoblasts and osteoclasts were markedly increased in secondary spongiosa in the PGE2-injected limbs. This finding confirmed a stimulatory role of PGE2 in the bone formation. The local intraosseous injection of PGE2 was proven to be a good model for the study of local growth factors on bone metabolism with a lower effective dose which eliminates the systemic side effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453506     DOI: 10.1007/bf00675627

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  23 in total

1.  A quantitative histologic analysis of the growing long bone metaphysis.

Authors:  D B Kimmel; W S Jee
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

2.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

3.  Long-term low-dose prostaglandin E1 administration.

Authors:  K Sone; M Tashiro; T Fujinaga; T Tomomasa; K Tokuyama; T Kuroume
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

4.  Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.

Authors:  W S Jee; S Mori; X J Li; S Chan
Journal:  Bone       Date:  1990       Impact factor: 4.398

5.  Effect of platelet derived growth factor on heterotopic bone formation in rats.

Authors:  O Risto; O Wahlström; A Abdiu; T Walz
Journal:  Acta Orthop Scand       Date:  1991-02

6.  Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats.

Authors:  H Z Ke; W S Jee; S Mori; X J Li; D B Kimmel
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

7.  Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.

Authors:  S Mori; W S Jee; X J Li
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

8.  Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo.

Authors:  S C Marks; S Miller
Journal:  J Oral Pathol       Date:  1988-11

9.  The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation.

Authors:  W S Jee; K Ueno; Y P Deng; D M Woodbury
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

10.  Bone cell kinetics during longitudinal bone growth in the rat.

Authors:  D B Kimmel; W S Jee
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

View more
  14 in total

1.  [Tissue engineering of cartilage and bone : growth factors and signaling molecules].

Authors:  C Brochhausen; M Lehmann; R Zehbe; B Watzer; S Grad; A Meurer; C J Kirkpatrick
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

Review 2.  Mechanotransduction and the functional response of bone to mechanical strain.

Authors:  R L Duncan; C H Turner
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

Review 3.  Anabolic agents and bone quality.

Authors:  Tarek Sibai; Elise F Morgan; Thomas A Einhorn
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

4.  Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans.

Authors:  H Langberg; D Skovgaard; L J Petersen; J Bulow; M Kjaer
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

Review 5.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

6.  Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Authors:  Sasanka Ramanadham; Kevin E Yarasheski; Matthew J Silva; Mary Wohltmann; Deborah Veis Novack; Blaine Christiansen; Xiaolin Tu; Sheng Zhang; Xiaoyong Lei; John Turk
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

7.  Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo.

Authors:  J D Bradley; D G Cleverly; A M Burns; N B Helm; M J Schmid; D B Marx; D M Cullen; R A Reinhardt
Journal:  J Periodontal Res       Date:  2007-06       Impact factor: 4.419

8.  Dietary lipids, prostaglandin E2 levels, and tooth movement in alveolar bone of rats.

Authors:  P P Kokkinos; R Shaye; B S Alam; S Q Alam
Journal:  Calcif Tissue Int       Date:  1993-11       Impact factor: 4.333

9.  Chronic intramedullary infusion of interleukin-1 alpha increases bone mineral content in rats.

Authors:  M Takada; I Yamamoto; R Morita
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

10.  In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells.

Authors:  Benjamin J Frisch; Rebecca L Porter; Benjamin J Gigliotti; Adam J Olm-Shipman; Jonathan M Weber; Regis J O'Keefe; Craig T Jordan; Laura M Calvi
Journal:  Blood       Date:  2009-09-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.